Dependent variable | Predictors | B (SE) | Standardized B | p Value | Model |
---|---|---|---|---|---|
Number of joints with erosion | Number of joints with DECT MSU crystal deposition | 0.33 (0.09) | 0.39 | 0.001 | R2=0.40, F=14.2, p<0.001 |
Subcutaneous tophus count | 0.09 (0.03) | 0.33 | 0.002 | ||
Serum urate concentration (mmol/L) | −0.24 (1.59) | −0.01 | 0.88 | ||
Disease duration (years) | 0.01 (0.02) | 0.03 | 0.70 | ||
Total erosion score | Number of joints with DECT MSU crystal deposition | 2.30 (0.42) | 0.49 | <0.001 | R2=0.60, F=32.2, p<0.001 |
Subcutaneous tophus count | 0.58 (0.13) | 0.37 | <0.001 | ||
Serum urate concentration (mmol/L) | 1.39 (7.19) | 0.02 | 0.85 | ||
Disease duration (years) | 0.10 (0.07) | 0.10 | 0.16 | ||
Number of joints with joint space narrowing | Number of joints with DECT MSU crystal deposition | −0.01 (1.20) | −0.02 | 0.87 | R2=0.29, F=9.0, p<0.001 |
Subcutaneous tophus count | 0.11 (0.02) | 0.54 | <0.001 | ||
Serum urate concentration (mmol/L) | 1.13 (1.20) | 0.09 | 0.35 | ||
Disease duration (years) | 0.00 (0.01) | 0.03 | 0.78 | ||
Total joint space narrowing score | Number of joints with DECT MSU crystal deposition | −0.04 (0.18) | −0.03 | 0.82 | R2=0.23, F=6.6, p<0.001 |
Subcutaneous tophus count | 0.25 (0.06) | 0.48 | <0.001 | ||
Serum urate concentration (mmol/L) | 2.51 (3.18) | 0.08 | 0.43 | ||
Disease duration (years) | 0.01 (0.03) | 0.04 | 0.65 | ||
Number of joints with spur | Number of joints with DECT MSU crystal deposition | 0.28 (0.06) | 0.52 | <0.001 | R2=0.48, F=18.7, p<0.001 |
Subcutaneous tophus count | 0.04 (0.02) | 0.23 | 0.02 | ||
Serum urate concentration (mmol/L) | 0.15 (0.95) | 0.01 | 0.88 | ||
Disease duration (years) | 0.01 (0.01) | 0.01 | 0.56 | ||
Number of joints with osteophyte | Number of joints with DECT MSU crystal deposition | 0.12 (0.06) | 0.25 | 0.06 | R2=0.18, F=4.77, p=0.002 |
Subcutaneous tophus count | 0.03 (0.02) | 0.19 | 0.12 | ||
Serum urate concentration (mmol/L) | 1.15 (1.05) | 0.11 | 0.28 | ||
Disease duration (years) | 0.00 (0.01) | −0.01 | 0.96 | ||
Number of joints with periosteal new bone formation | Number of joints with DECT MSU crystal deposition | 0.11 (0.05) | 0.29 | 0.03 | R2=0.14, F=3.5, p=0.01 |
Subcutaneous tophus count | 0.02 (0.02) | 0.15 | 0.22 | ||
Serum urate concentration (mmol/L) | −0.72 (0.82) | −0.10 | 0.39 | ||
Disease duration (years) | 0.00 (0.01) | 0.01 | 0.89 | ||
Number of joints with sclerosis | Number of joints with DECT MSU crystal deposition | 0.27 (0.09) | 0.35 | 0.002 | R2=0.37, F=12.7, p<0.001 |
Subcutaneous tophus count | 0.08 (0.03) | 0.32 | 0.003 | ||
Serum urate concentration (mmol/L) | −0.29 (1.5) | −0.02 | 0.85 | ||
Disease duration (years) | 0.02 (0.02) | 0.11 | 0.19 |
DECT, dual-energy CT; MSU, monosodium urate.